Genetic diseases are the main cause of death among infants and are responsible for 20-30% of the total annual infant mortality rate¹. Everyone carries mutations in their genes but not all mutations are pathogenic, i.e. have an effect on our health and development. Genetic diseases are caused by mutations and can be either dominant – caused by a pathogenic mutation in just one copy of a chromosome, or recessive – caused by pathogenic mutations in both copies. If someone has a recessive mutation in only one copy of the gene, that person is considered a “carrier”, but has not inherited the disease.
Usually, carriers of genetic diseases are not aware of their status as they do not exhibit any symptoms and can pass it down to their children. Carrier screening tests that can inform individuals whether they are carriers of a genetic disease, are crucial to minimize the risk of transmitting the disease to their children. When testing is carried out before pregnancy, it can provide information that can guide reproductive choices and offer more time to take appropriate decisions. In case carrier screening is performed during pregnancy, it can help parents better prepare for the birth of their children. Some genetic diseases that are frequently prevalent and have moderate to severe clinical phenotype, can affect quality of life and can often be managed through early interventions.
The results of a carrier screening test can be either positive, meaning that a pathogenic or likely pathogenic mutation has been identified and that the person is a carrier of the genetic disease; or negative, meaning that a pathogenic or likely pathogenic mutation has not been identified. If a pathogenic autosomal recessive mutation is detected in the same gene in both parents, then there is a 25% risk of the child being born with the genetic disease, and 50% risk of being a carrier like the parents. In case a pathogenic mutation is detected only in one of the parents, then the child has 50% risk of becoming a carrier of the disease².
Screening programs for the detection of carriers of severe genetic diseases have been active around the world for many years, with most of them focusing on β-thalassemia. B-thalassemia is one of the most common hereditary single gene diseases around the world and is the most widespread genetic disease amongst the Cypriot population. Cyprus has the highest percentage of healthy carriers of β-thalassemia worldwide⁴’⁵’⁶. Carrier screening programs for β-thalassemia have been active in Cyprus since 1973. After the implementation of the program, the number of affected babies fell from 51 in 1974 to only 8 in 1979⁴. The number of affected babies kept dropping, with only 5 total affected births between the years of 1991 to 2001⁶. Cyprus’ screening program is one of the most successful programs in the world as far as hereditary hemoglobin diseases are concerned.
According to the American Congress of Obstetricians and Gynecologists (ACOG) and the American College of Medical Genetics and Genomics (ACMG), information about carrier screening testing should be provided to all pregnant women, as well as to those who are planning to start a family. Carrier screening tests can be beneficial for any individual wishing to know more about their carrier profile, couples planning to start their families or who are already expecting, candidate gamete donors for parent-donor compatibility, population groups that are at high risk for specific diseases, and for people who have a known family history of a genetic mutation.
The information obtained with such genetic tests can offer healthcare providers and individuals, couples or prospective parents useful genetic insight into one’s carrier status. Carrier screening tests can inform, guide and empower people on their reproductive choices; help them evaluate their options and take informed decisions regarding prevention and therapy of genetic diseases that may be manageable through early interventions.
- Berry RJ, Buehler JW, Strauss LT, et al. 1987. Birth weight-specific infant mortality due to congenital abnormalities, 1960 and 1980. Public Health Report 102:171-81
- National Library of Medicine National Institutes of Health, (2020), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758394/
- The American College of Obstetricians and Gynecologists,(2018), https://www.acog.org/Patients/FAQs/Carrier-Screening
- Onmed.gr, (2015), https://www.onmed.gr/ygeia/story/326064/ti-simainei-na-eisai-foreas-mias-astheneias
- National Library of Medicine National Institutes of Health, (2020), https://www.ncbi.nlm.nih.gov/pubmed/19390864
- Ministry of Health Cyprus, (2018)
- Cousens, Nicole E et al. “Carrier screening for beta-thalassaemia: a review of international practice.” European Journal of Human Genetics: EJHG vol. 18,10 (2010): 1077-83. doi:10.1038/ejhg.2010.90
- Nazareth, S. B., Lazarin, G. A., & Goldberg, J. D. (2015). Changing trends in carrier screening for genetic disease in the United States. Prenatal Diagnosis, 35(10), 931–935.https://doi.org/10.1002/pd.4647
NIPD Genetics is a leading, innovative biotechnology company that designs, develops, and provides a broad spectrum of healthcare services to its customers through its expansive portfolio of molecular and clinical laboratory tests in all disciplines.
At NIPD Genetics we are committed to protecting and respecting our customer’s privacy and personal information. Personal information or personal data means any information that identifies, relates to, describes, is capable of being associated with, or could be reasonably linked, directly or indirectly, with a particular individual, such as name, identification number, location data, an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that individual.
NIPD Genetics collects and processes your personal information according to the General Data Protection Regulation (EU) 2016/679 and the Cypriot law providing for the protection of natural persons with regards to the processing of personal data and for the free movement of such data (L. 125(I)/2018). The following principles lie at the heart of our approach to handling personal data:
- Lawfulness, fairness and transparency – We collect and process personal data in a lawful and transparent manner and clearly communicate to our customers how their personal data will be used.
- Purpose limitation – We only use personal data for the purpose for which they have been collected.
- Data minimization – We only collect the data that is absolutely necessary in relation to the purposes for which they are processed.
- Accuracy – We take every reasonable step to ensure that personal data collected are accurate and up to date.
- Storage limitation – We do not keep personal data for longer than it is needed. Personal data are periodically reviewed and erased if they are not needed or anonymized and stored for scientific research purposes.
- Integrity and confidentiality (security) – Appropriate technical and organizational measures are in place to ensure that personal data are adequately protected from any unauthorised or illegal processing and accidental loss, destruction or damage.
- Accountability – We, at NIPD Genetics, are committed to compliance with all legal requirements and promote internal practices to achieve the highest standards for personal data privacy.
NIPD Genetics has appointed a Data Protection Officer (DPO) who is responsible for overseeing and ensuring that personal information is collected and processed in line with these principles. The contact details of the Data Protection Officer (DPO) can be found below:
Email address: firstname.lastname@example.org
Postal address: 31 Neas Engomis street, 2409 Engomi, Nicosia, Cyprus
Telephone number: + 357 22266888
PERSONAL INFORMATION COLLECTION AND PROCESSING
We collect and process several types of personal information from and about users of our websites and of our products and services, including:
- Personal and sensitive information: some of our products and services may involve testing of biological samples that we or our customers use to create test reports, genotyping or sequencing services for research or clinical purposes and the receipt, creation, or analysis of genomic or other data derived from samples, including through our customer’s use of our software as a service product. In receiving samples and providing our products and services, we may obtain your name and surname, date of birth, email address, home address, telephone number, gender, ethnicity and other health related information.
- Computer, device and browsing information: as you interact with our products and services online, including this website, we may use automatic data collection technologies to collect certain information about your computer or device, as well as browsing actions and usage patterns. This data may include your IP address, browser type or version. The technologies we use for this automatic data collection may include cookies. You can control cookies by adjusting your cookies settings.
Information about children
If you are under 18 years of age, do not register on our website or provide any information about yourself to us. We do not provide our products or services directly to children or proactively collect their personal information. Despite this prohibition, it is possible that we may sometimes be given information about children while handling samples from our customers in our clinical labs, or through use of our products and services by our customers and partners. If we become aware that we have inadvertently collected personal information from children under the age of 18, without parental consent, we will take the necessary steps to delete it as soon as possible in compliance with applicable laws.
LEGAL BASIS FOR PROCESSING OF YOUR PERSONAL INFORMATION
Your personal information is collected by NIPD Genetics for the following purposes:
- To provide you with our products and services, respond to your inquiries or fulfill your requests and otherwise manage your relationship with us. The legal basis for processing is to meet the requirements of a contract, to comply with our legal obligations and/or because we have a legitimate interest in responding to requests for information about our products and services.
- To communicate with you about content and product offerings, newsletters and event invitations which are relevant to your interests and in line with your preferences. The legal basis for processing is the individual’s explicit consent prior to sending the information and managing individuals preferences.
- To process and respond to complaints. The legal basis for processing is to meet a legal obligation.
- To monitor and record information relating to the use of our products and services, including our website. The legal basis for processing is our legitimate interest in order to improve our products and services and our website for individuals.
To provide our products and services, NIPD Genetics may collect, receive and process biological samples to isolate and sequence DNA. NIPD Genetics may then store resulting genetic information and use genetic information to provide our products and services. In some cases, NIPD Genetics may provide interpretations of genetic information on behalf of its customers, including healthcare providers. This is only done pursuant to a written contract or a Sample Information Form with a patient’s informed consent and is subject to applicable legal and ethical safeguards.
This sensitive information described above is collected by NIPD Genetics for the following purposes:
- To provide support and maintenance services to customers who use our products and services – The legal basis for processing is to meet the requirements of a contract.
- To provide genotyping and sequencing services and analysis for our customers, including healthcare providers. The legal basis of this processing is to meet the requirements of a contract or as allowed in the Sample Information Form with a patient’s informed consent.
- To conduct genotyping and sequencing services and analysis for quality control, process and product development and improvements, and optimization in our labs to reflect quality improvements and advances in our technology. The legal basis for processing is the patient’s informed consent given through the Sample Information Form.
Transfer of Data
Your information, including personal data, may be transferred to - and maintained on - computers located outside your province, country or other governmental jurisdiction where the data protection laws may differ than those from your jurisdiction.
If you are located outside Cyprus and choose to provide information to us, please note that we transfer the data, including personal data, to Cyprus and process it there.
Disclosure of Data
NIPD Genetics complies with the General Data Protection Regulation and will not sell or trade your personal information.
NIPD Genetics may disclose your personal information in the good faith that such action is necessary:
- To comply with a legal obligation
- To protect and defend the rights or property of NIPD Genetics
- To prevent or investigate possible wrongdoing in connection with our products and services
- To protect against legal liability
COOKIES AND OTHER TRACKING TECHNOLOGIES
Cookies are files with small amount of data which may include an anonymous unique identifiers. Cookies are sent to your browser when you visit a website and stored on your device. Tracking technologies used on the website are beacons, tags and scripts, to collect and track information and to improve and analyze our websites.
You can instruct your browser to refuse all cookies or to indicate when a cookie is being sent. However, if you do not accept cookies, you may not be able to use some portions of our websites.
Examples of Cookies we may use:
Session Cookies. We use Session Cookies to operate our websites.
Preference Cookies. We use Preference Cookies to remember your preferences and various settings.
Security Cookies. We use Security Cookies for security purposes.
Visitor behavior cookies. To understand how visitors use and navigate the websites
Keyword cookies. To understand how visitors discover the websites.
We may use third-party Service Providers to monitor and analyze the use of our websites.
Google Analytics is a web analytics service offered by Google that tracks and reports website traffic. Google uses the data collected to track and monitor the use of our service. This data is shared with other Google services. Google may use the collected data to contextualize and personalize the ads of its own advertising network.
For more information on the privacy practices of Google, please visit the Google Privacy & Terms web page
SECURITY OF DATA
PERSONAL DATA RETENTION
We may employ third party companies and individuals to facilitate, maintain or operate our websites (“Service Providers”), to provide the websites on our behalf, to perform service-related services or to assist us in analyzing how our websites are used.
These third parties have access to your Personal Data only to perform these tasks on our behalf and are obligated not to disclose or use it for any other purpose.
LINKS TO OTHER SITES
We have no control over and assume no responsibility for the content, privacy policies or practices of any third-party sites or services.
YOUR LEGAL RIGHTS
NIPD Genetics ensures that it can respond immediately to requests that you make for the exercise of your legal rights in accordance with data protection laws. These rights are as follows:
- The right to withdraw consent at any time – in cases where processing is based on your consent
- The right of access – at any given time you have the right to know what information about you we hold and receive information about the processing activities we perform
- The right to rectify – you have the right to correct, amend and complete personal data that is incomplete
- The right to erasure (“right to be forgotten”) – you can request that your personal information is deleted
- The right to object – you can object at any time to our processing of your personal information
- The right to restriction of processing – this applies in the event:
- You dispute the accuracy of your personal information and until it is verified
- You oppose to the deletion of personal data and ask instead to delete the use of it
- The personal information is no longer necessary for us
- You object to the processing and we are considering whether our legitimate grounds for processing prevail over the reasons you oppose to the processing
- The right to data portability – at any given time you have the right to receive the personal information we hold about you in a structured, commonly used and machine-readable format (pdf, word etc.). You also have the right to request that these data are transferred to another service in a safe and secure way
You also have the right to lodge a complaint at any time to the Office of the Commissioner for Personal Data Protection.
Effective date: 18/06/2021
Carrier screening is a type of genetic test that can tell you whether you carry a gene for certain genetic disorders. When it is done before or during pregnancy, it allows you to find out your chances of having a child with a genetic disorder.What conditions are tested in carrier screening? ›
We recommend that all women consider having carrier screening for cystic fibrosis, spinal muscular atrophy (SMA), sickle cell disease and other hemoglobin disorders. A number of genetic disorders occur more frequently in certain ethnic populations.How do you screen for genetic disorders? ›
They include carrier screening and prenatal genetic screening tests: Carrier screening is done on parents (or those just thinking about becoming parents) using a blood sample or tissue sample swabbed from inside the cheek. These tests are used to find out whether a person carries a gene for certain inherited disorders.What are 3 ways genetic screening can be done? ›
- Molecular tests look for changes in one or more genes. ...
- Chromosomal tests analyze whole chromosomes or long lengths of DNA to identify large-scale changes. ...
- Gene expression tests look at which genes are turned on or off (expressed) in different types of cells.
Since being a carrier for one or more genetic conditions is very common, anyone who is pregnant or planning to become pregnant should consider having genetic carrier screening. The results can provide you with important information about your chances to have a child with certain genetic conditions.How accurate is genetic carrier screening? ›
Some tests are more accurate than others. On average, carrier screens have a detection rate greater than 90%.When do you need a carrier screening? ›
Carrier screening and counseling ideally should be performed before pregnancy because this enables couples to learn about their reproductive risk and consider the most complete range of reproductive options, including whether or not to become pregnant and whether to use advanced reproductive technologies such as ...How long does genetic carrier screening take? ›
Once a sample of your blood, saliva or tissue is taken, a lab will isolate the DNA from your cells to perform the screening. Because most hospitals have to send your blood to an off-site laboratory to do carrier testing, it will likely take between one and two weeks to get your results.Does insurance cover genetic carrier testing? ›
Most health insurance plans will cover the cost of genetic testing when recommended by a physician. However, all coverage and reimbursement is subject to Medicare, Medicaid, and third-party payer benefit plans.What is the most common form of genetic screening? ›
Newer testing called cell-free DNA testing looks at a baby's DNA via a blood test done on the mother. Newborn screening. This is the most common type of genetic testing. In the United States, all states require that newborns be tested for certain genetic and metabolic abnormalities that cause specific conditions.
- Molecular genetic tests (or gene tests) ...
- Chromosomal genetic tests. ...
- Biochemical tests. ...
- Newborn screening. ...
- Diagnostic testing. ...
- Carrier testing. ...
- Prenatal testing. ...
- Pre-implantation testing.
Genetic testing is focused on an individual; genetic screening is really focused on a whole population of people, trying to identify those specifically who are [at] increased risk to develop it or to have children with a condition in question or the condition being screened for.Why do doctors push genetic testing? ›
Genetic testing can help identify an inherited condition or disease risk. The test results might help you and your doctor: Choose ways to prevent or treat a condition. Decide which screening tests you need (to find a disease at an early stage when it might be more treatable).What is the best method of genetic testing? ›
For small DNA mutations, direct DNA testing is typically the most effective method, particularly if the function of the protein is unknown and a biochemical test cannot be developed. A DNA test can be performed on any tissue sample and requires very small amounts of sample.
Who Should Get Genetic Testing? You should consider getting genetic testing if you have: A recent or current cancer diagnosis at a young age. Multiple types of any cancer or multiple people with cancer in your family.Does genetic testing show autism? ›
Genetic testing looks for causes of ASD but cannot be used to diagnose ASD. Some people with ASD have syndromic ASD, meaning that they have other specific features in addition to having ASD, such as looking different from other people in the family or having birth defects.Does everyone carry a genetic disease? ›
Myth: You only need carrier screening if you are Jewish—or Ashkenazi Jewish. Fact: While everyone is at risk of carrying genetic diseases, testing is especially important for people with a higher risk level.Can genetic blood test be wrong? ›
Rarely, tests results can be false negative, which occur when the results indicate a decreased risk or a genetic condition when the person is actually affected. In some cases, a test result might not give any useful information. This type of result is called uninformative, indeterminate, inconclusive, or ambiguous.Do both parents have to be carriers of a disease? ›
Parents can have a baby with a genetic condition even though neither parent has it. Babies inherit two copies of each gene, one from each parent. For some genetic conditions, the baby will only have the condition if both copies of the gene related to the condition do not work properly.What does it mean to be a carrier of a genetic disorder? ›
A carrier, as related to genetics, is an individual who “carries” and can pass on to its offspring a genomic variant (allele) associated with a disease (or trait) that is inherited in an autosomal recessive or sex-linked manner, and who does not show symptoms of that disease (or features of that trait).
Laboratory tests, including genetic testing: Molecular, chromosomal, and biochemical genetic or genomic testing are used to diagnose genetic disorders. Other laboratory tests that measure the levels of certain substances in blood and urine can also help suggest a diagnosis.What are the chances that my partner and I are carriers for the same genetic disease? ›
If you and your partner are both carriers of the same recessive disease, there is a 25% risk that your child will be born with that disease. There is a 50% chance that your child will be a carrier with no symptoms of the disorder, and a 25% chance that your child will not inherit the gene mutation from either parent.Why is genetic testing not covered by insurance? ›
Passed in 2008, a federal law called the Genetic Information Nondiscrimination Act (GINA) made it illegal for health insurance providers in the United States to use genetic information in decisions about a person's health insurance eligibility or coverage.Can genetic testing be used against you? ›
Your genetic information could also potentially be used against you in a court case. If you were to seek damages for a work-related injury, for example, a company might try to use information from your genome to point to potential other causes for your symptoms.Does labcorp do genetic carrier testing? ›
Choice in carrier screening
And Inheritest offers choice in testing, with options that screen from three hereditary disorders to more than 110. Ask your doctor which panel may be right for you, and visit our website for details on disorders we screen for.
You and your partner may want to consider genetic testing before conceiving if either one of you don't know your family history, as is often the case when adoption is involved. Genetic testing can also be a valuable risk assessment tool for couples who already have one child with a birth defect or genetic disorder.What does it mean to be a carrier of an inherited disease? ›
A carrier, as related to genetics, is an individual who “carries” and can pass on to its offspring a genomic variant (allele) associated with a disease (or trait) that is inherited in an autosomal recessive or sex-linked manner, and who does not show symptoms of that disease (or features of that trait).Why is carrier screening important? ›
Carrier screening is important because it helps us discover whether a patient is a carrier of serious inheritable genetic conditions, including cystic fibrosis, spinal muscular atrophy, Tay Sachs and sickle cell disease. We can also test for many other conditions.What does myriad carrier screening test for? ›
If you're pregnant, the Myriad Prequel Prenatal Screen is a noninvasive screen ordered by your healthcare provider that you can take as early as 10 weeks into your pregnancy to learn about your baby's chance of having a chromosome abnormality leading to a condition like Down syndrome.Does insurance cover genetic carrier testing? ›
Most health insurance plans will cover the cost of genetic testing when recommended by a physician. However, all coverage and reimbursement is subject to Medicare, Medicaid, and third-party payer benefit plans.
Genetic testing looks for causes of ASD but cannot be used to diagnose ASD. Some people with ASD have syndromic ASD, meaning that they have other specific features in addition to having ASD, such as looking different from other people in the family or having birth defects.What are examples of carrier genetic diseases? ›
- Agenesis of the Corpus Callosum with Peripheral Neuropathy.
- Autosomal Recessive Polycystic Kidney Disease.
- Beta Thalassemia and Related Hemoglobinopathies.
- Bloom Syndrome.
- Canavan Disease.
- Congenital Disorder of Glycosylation Type 1a (PMM2-CDG)
Recessive inheritance means both genes in a pair must be abnormal to cause disease. People with only one defective gene in the pair are called carriers. These people are most often not affected with the condition. However, they can pass the abnormal gene to their children.Which parents genes are more dominant? ›
And while it is true that you get half of your genes from each parent, the genes from your father are more dominant, especially when it comes to your health.How long does genetic carrier screening take? ›
Once a sample of your blood, saliva or tissue is taken, a lab will isolate the DNA from your cells to perform the screening. Because most hospitals have to send your blood to an off-site laboratory to do carrier testing, it will likely take between one and two weeks to get your results.Do both parents have to be carriers of a disease? ›
Parents can have a baby with a genetic condition even though neither parent has it. Babies inherit two copies of each gene, one from each parent. For some genetic conditions, the baby will only have the condition if both copies of the gene related to the condition do not work properly.How much does myriad carrier screening cost? ›
At Myriad, we understand that each situation is unique. Therefore, we have designed programs to make sure testing is affordable for everyone. Through excellent insurance and financial assistance, 75% of patients who undergo myRisk testing pay $0 and 90% of patients pay $100 or less.How much does myriad genetic testing cost? ›
These tests can cost up to $4000. However, Myriad claims that 97% of private health insurance companies cover its testing. The company also offers a financial assistance program. This program may cap expenses at $295 for individuals who qualify.How accurate is myriad genetic testing? ›
99.98 percent* analytic sensitivity. 14-21 days for test turnaround time. 97 percent of private insurance companies cover Myriad's hereditary cancer genetic testing.